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Abstract
6-Shogaol is an active compound isolated from Ginger (Zingiber officinale Rosc). In this work, we demonstrated that 6-
shogaol induces apoptosis in human hepatocellular carcinoma cells in relation to caspase activation and endoplasmic
reticulum (ER) stress signaling. Proteomic analysis revealed that ER stress was accompanied by 6-shogaol-induced apoptosis
in hepatocellular carcinoma cells. 6-shogaol affected the ER stress signaling by regulating unfolded protein response (UPR)
sensor PERK and its downstream target eIF2a. However, the effect on the other two UPR sensors IRE1 and ATF6 was not
obvious. In prolonged ER stress, 6-shogaol inhibited the phosphorylation of eIF2a and triggered apoptosis in SMMC-7721
cells. Salubrinal, an activator of the PERK/eIF2a pathway, strikingly enhanced the phosphorylation of eIF2a in SMMC-7721
cells with no toxicity. However, combined treatment with 6-shogaol and salubrinal resulted in significantly increase of
apoptosis and dephosphorylation of eIF2a. Overexpression of eIF2a prevented 6-shogaol-mediated apoptosis in SMMC-
7721 cells, whereas inhibition of eIF2a by small interfering RNA markedly enhanced 6-shogaol-mediated cell death.
Furthermore, 6-shogaol-mediated inhibition of tumor growth of mouse SMMC-7721 xenograft was associated with
induction of apoptosis, activation of caspase-3, and inactivation of eIF2a. Altogether our results indicate that the PERK/eIF2a
pathway plays an important role in 6-shogaol-mediated ER stress and apoptosis in SMMC-7721 cells in vitro and in vivo.
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Introduction
Ginger, derived from the rhizome of Zingiber officinale Rosc, is
one of the most widely used spices around the world. It has been
used as a common condiment in foods and beverages more than
2500 years [1]. In recent years, Ginger has received extensive
attention as a botanical dietary supplement in the USA and
Europe because of its anti-inflammatory, anti-oxidative and anti-
tumor activities [1,2]. 6-Shogaol (Figure 1A), the dehydration
products of 6-gingerol, extracted from Ginger, exhibits much
stronger anti-tumor activity than 6-gingerol [3]. In recent studies,
6-shogaol was reported to exhibit anti-tumor activity in various
tumor cell lines [4–8]. However, detailed anti-tumor molecular
mechanism of 6-shogaol in human hepatocellular carcinoma
(HCC) cells still remains unclear.
Apoptosis is defined as a programmed cell death and has been
proposed as an efficient anti-tumor mechanism. Malignant tumor
cells can be eliminated after treatment with anticancer chemo-
therapies though apoptosis [9]. Recent studies suggested that
apoptosis is coupled with ER stress [10,11]. ER serves as a
central organelle engaged in regulating protein synthesis, protein
folding and intracellular calcium level, failure of which will cause
ER stress [12,13]. ER stress triggers signaling pathway termed as
‘‘unfolded protein response’’ (UPR) and leads to apoptosis if the
ER stress becomes prolonged and severe [14]. The UPR is
primarily regulated by three ER proximal sensors: PKR-like ER-
associated kinase (PERK), activating transcription factor 6
(ATF6), and inositol requiring enzyme-1 (IRE1) [15]. During
ER stress, PERK is dissociated from GRP78/BiP and turns to its
phosphorylated form and then initiates the phosphorylation of
eIF2a [16,17]. eIF2a phosphorylation is required for cell survival
by limiting the protein-folding load to prevent accumulation of
misfolded proteins [18], and the subsequent additional stress [19–
21]. In the absence of eIF2a phosphorylation, cells exhibit a
higher rate of protein synthesis thus the demand for protein
folding will increase. This includes increased pro-insulin folding
and misfolding, and the later leads to accumulation of misfolded
protein in the ER, thereby enhanced cell death [22–24].
In this work, a comparative proteomics approach was used to
identify proteins alteration and explore the possible molecular
basis of 6-shogaol-induced apoptosis in SMMC-7721 cells. The
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dimensional gel electrophoresis (2-DE) and LC-MS/MS. The
UPR related proteins were further confirmed by western blot
analysis. Through pharmacologic and genetic approaches, we
demonstrated that the inhibition of eIF2a phosphorylation plays a
pivotal role in 6-shogaol induced ER stress and apoptosis in
SMMC-7721 cells in vitro and in vivo.
Materials and Methods
Cell Lines and Chemicals
HepG2 cells were purchased from American Type Culture
Collection (Manassas, VA, USA). SMMC-7721, BEL-7404 and
HL-7702 cells were purchased from Cell Bank of Chinese
Academy of Sciences, Shanghai. 6-Shogaol was separated from
ginger supercritical fluid extraction. Salubrinal was purchased
from Alexis (Carlsbad, CA, USA). Antibodies against GRP78,
GADD153, GRP94, PERK, eIF2a, phospho-eIF2a, PARP,
HSP70, caspase-3, IRE1 were purchased from Cell Signaling
Technology (Beverly, MA); Anti-b-actin and phospho-PERK
antibodies were from Santa Cruz Biotechnology (Santa Cruz,
CA, USA); Anti-ATF6 antibody was from Millipore (Billerica,
MA, USA) and antibodies against phospho-IRE1, Calpain-1,
Calpain-2 were from Abcam (Cambridge, MA, USA). All the
other chemicals were purchased from either Amersham Biosci-
ences or Sigma-Aldrich.
Apoptosis Assay
The following methods were used to assess drug-induced
apoptotic cell death: The cytotoxicity of 6-shogaol was evaluated
by MTT assay. Morphological changes of apoptosis were stained
with Hoechst 33258 and detected by fluorescence microscopy.
The apoptotic cells were determined by flow cytometry as
described before [25]. DNA laddering was practiced according to
Genomic DNA Purificaion Kit (Promega, WI, USA). DNA
degradation was detected by flow cytometric analysis.
Figure 1. Effect of 6-shogaol on viability and apoptosis in HCC cells. (A) The chemical structure of 6-shogaol. (B) SMMC-7721, BEL-7404 and
HepG2 cells were treated with 5, 10, 15, 20, 25, 30, 40 and 50 mM 6-shogaol for 24 h respectively, and the cell viability was determined by MTT assay.
(C) SMMC-7721 cells were treated with 5, 10, 15, 20, 25 and 30 mM 6-shogaol for 24, 48, and 72 h respectively, and the cell viability was examined by
MTT assay. (D) Cells (1610
6) were treated with 20 mM 6-shogaol for 24 h and stained with Hoechst 33258. Original magnification6400. (E) Cells were
treated with 20 mM 6-shogoal for 12 and 24 h. DNA frangemntation was determined. (F and G) SMMC-7721 cells were treated with 20 mM 6-shogaol
for 3, 6, 12 and 24 h. The cells were stained with Annexin V/PI, and apoptosis was determined using flow cytometry. (H) Normal human liver HL-7702
cells were treated with 20, 40, and 80 mM 6-shogaol for 24 h. Apoptosis was determined using flow cytometry.
doi:10.1371/journal.pone.0039664.g001
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The activity of caspase-3 assay was carried out according to
Caspase-3 Activity Assay Kit (Beyotime, Haimen, China). The
caspase-3 activity assay is based on spectrophotometric detection
of the chromophore p-nitronanilide (p-NA), after its cleavage from
the labeled substrate, acetyl-Asp-Glu-Val-Asp p-nitroanilide (Ac-
DEVD-pNA). Briey, SMMC-7721 cells were lysed after treatment
with 6-shogaol (20 mM). Assays were performed on 96-well plates
by incubating 30 mg total protein of cell lysate per sample and add
reaction buffer (1% NP-40, 20 mM Tris–HCl (pH 7.5), 137 mM
Nad, and 10% glycerol) to a total volume of 90 mL, containing
10 mL caspase-3 substrate (Ac-DEVD-pNA) (2 mM). Lysates were
incubated at 37uC for 4 h. Samples were measured with an
enzyme-linked immune-sorbent assay (ELISA) reader at an
absorbance of 405 nm and the caspase activities were expressed
as the percentage of enzyme activity compared with the control
group. All the experiments were performed in triplicate.
Two-dimensional Gel Electrophoresis (2-DE)
The total cellular proteins (300 mg) were diluted to 350 mLi n
hydration solution (8 M urea, 2 M thiourea, 4% CHAPS, 20 mM
tris, 65 mM DTT and 0.5% IPG buffer), and then loaded on the
Ready-Strip IPG strips (18 cm, pH 3–10, Nonlinear, Bio-Rad) for
IEF. The strips were placed into Amersham Biosciences IPGphor
IEF (Amersham) and were rehydrated and then separated based
on pI. After IEF, the IPG strips were equilibrated for 15 min in a
buffer containing 50 mM Tris-HCl, pH 6.8, 30% glycerol, 6 M
urea, 1% SDS, and 0.2% DTT, followed by further treatment to
prevent reformation of disulfide bonds in a similar buffer (but
containing 3% iodoacetamide instead of DTT) for 15 min and
then directly applied onto 12.5% homogeneous SDS-PAGE gels
for electrophoresis using a Protean II xi cell system (Bio-Rad,
USA). The gels were then stained with coomassie brilliant blue
and analyzed with the Image-Master 2D Platinum software (GE
Healthcare). For each experiment, the gels were run in triplicate.
Protein Spot In-gel Enzymatic Digestion and LC-ESI-MS/
MS Identification
The protein spots of interest were excised, distained and
digested with trypsin (Promega, WI, USA). The supernatant
peptide were sequentially extracted with peptide extraction
solution (5% formic acid (FA), 67% ACN) at 37uC for 30 min,
and then dissolved in sample buffer (2% ACN in water with 0.1%
FA) after drying and subjected to liquid chromatography (LC
Packings, Dionex, Sunnyvale, CA, USA) coupled with electrospray
ionisation tandem mass spectrometry (Esquire HCT, Bruker,
Germany). Data-dependent acquisition was controlled by chro-
meleon software (Dionex, Sunnyvale, CA, USA). The MS/MS
data was input to MASCOT 2.0 program (MatrixScience, Boston,
MA, USA) against IPI database v3.26 to identify the protein.
Stable eIF2a Over-expression and Knockdown Cell Lines
eIF2a cDNA was amplified by RT-PCR and cloned into the
lentivirus vector pWPI-Rho-GDI2 to obtain pWPI-Rho-GDI2-
eIF2a. eIF2a shRNA sequence was designed and double strand
oligonucleotides were synthesized and cloned onto the pLKO.1-
SH plasmid to obtain pLKO.1-SH-shRNA/eIF2a. Then the
plasmids were transformed into E. coli DH5a. Purified plasmids
form the positive clones confirmed by PCR and sequencing. 239T
cell lines were transfected with pWPI-Rho-GDI2, psPAX2, pMD
and pLKO.1-SH, psPAX2, pMD respectively to produce lentivi-
rus. The supernatant with lentivirus were collected and centrifuged
for 72 h to get positive lentivirus. The virus titer was determined
by real time PCR. SMMC-7721 cells were transduced with
lentivirus and selected for stable expression of the trans-gene by
the addition of 3 mg/mL puromycin.
Western Blot Analysis
After treatment, total cellular samples were washed twice with
cold PBS and lysed in RIPA lysis buffer. The total cellular protein
extracts were separated by SDS-PAGE, and transferred to
nitrocellulose membrane. Membranes were blocked with 5% fat-
free dry milk in 16TBS containing 0.05% Tween 20 under room
temperate for 2 h and incubated with primary antibodies at 4uC
overnight. Protein bands were detected by incubation with
horseradish peroxidase-conjugated antibodies, and visualized with
enhanced chemiluminescence reagent (Amersham, USA) as
reported [26].
Xenograft Assay
All animal studies were conducted according to protocols
approved by the Institutional Animal Care and Use Committee
(IACUC) of the China Pharmaceutical University (No. 20110302-
rat 32). Male SCID mice were purchased from Charles River
Laboratories (Wilmington, MA). A total of 3610
6 SMMC-7721
cells were inoculated subcutaneously into SCID mice. When the
tumors reached an average volume of about 0.1 cm
3, the mice
were randomly divided into control and treatment groups (n=8
animals per group). For the treatment groups, the mice were
administered with 6-shogaol (10 mg/kg or 50 mg/kg, i.p. for 28
days). The control group received the vehicle buffer alone. Tumor
size and body weight were measured after treatment at various
time intervals throughout the study. Tumor volumes were
calculated by the formula: length 6width
2 60.52 in millimeters.
At the termination of the experiment, mice were sacrificed at 24 h
after the last administration of compound. Tumor samples were
excised and weighed, then fixed in paraformaldehyde. Paraffin-
embedded tissues were sectioned and processed for H&E, TUNEL
and immunohistochemical staining.
TUNEL Assay
The apoptotic cells in tissue samples were detected using an In
Situ Cell Death Detection kit (Roche, Mannheim, Germany)
according to the manufacturer’s manual. After deparaffinization
and permeabilization, tissue sections were incubated with
proteinase K at room temperature for 15 min. The sections were
then incubated with the TUNEL reaction mixture that contains
terminal deoxynucleotidyl transferase (TdT) and fluorescein-
dUTP at 37uC for 1 h. After three times wash with PBS, the
sections were incubated with the Converter-POD which contains
anti-fluorescein antibody conjugated with horse-radish peroxidase
(POD) at room temperature for 30 minutes. Again, after three
times wash with PBS, the sections were incubated with 0.05% 3-
3’-diaminobenzidine tetrahydrochloride (DAB) and analyzed
under light microscope.
Histological and Immunohistochemical Evaluation
At the termination of xenograft experiments, tumor tissues from
representative mice were sectioned, embedded in paraffin, and
stained with hematoxylin and eosin for histopathologic evaluation.
For immunohistochemical analysis, tissue sections 4 mmi n
thickness were de-waxed and rehydrated in xylene and graded
alcohols. Antigen retrieval was performed with 0.01 M citrate
buffer at pH 6.0 in a 95uC water bath for 20 min. Slides were
allowed to cool for another 20 min, followed by sequential rinsing
in PBS and TBS-T buffer. Endogenous peroxidase activity was
6-Shogaol Induces Apoptosis in SMMC-7721 Cells
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peroxide. Each incubation step was carried out at room
temperature and was followed by three sequential washes (5 min
each) in TBS-T. After blocking with 10% goat serum for 1 h,
sections were incubated with primary antibodies, washed three
times in PBS, incubated with biotinylated secondary antibody for
1 h, followed by incubation with a streptavidin-peroxidase
complex for another 1 h. After three additional washes in PBS,
diaminobenzidine working solution was applied. Finally, the slides
were counterstained in hematoxylin.
Statistical Analysis
Data are presented as mean 6 SE for the indicated number of
independent experiments. Statistical differences between groups
were calculated using Student’s two-tailed t-test. Differences were
considered statistically significant for values p,0.05 or p,0.01.
Results
6-Shogaol-induced Apoptosis in HCC Cells in Dose- and
Time-dependent Manners
To investigate the cytotoxicity of 6-shogaol, several HCC cell
lines were incubated with various concentrations of 6-shogaol for
24 h, and the cell viability was examined by MTT assay. 6-
Shogaol exhibited cytotoxicity in all three HCC cells, SMMC-
7721 was the most susceptive one (Figure 1B). As shown in
Figure 1C, exposure of SMMC-7721 cells to 6-shogaol resulted in
viability decrease in a time-dependent manner. By Hoechst 33258
staining, 6-shogaol treated cells showed apoptotic phenotypes,
with signs of significant chromatin condensation, cell and nuclear
shrinkage (Figure 1D and Figure S1D). DNA laddering analysis
revealed that exposure of SMMC-7721 cells to 20 mM 6-shogaol
for 12 h resulted in a slight increase in cellular DNA degradation
and it became apparent after 24 h of drug exposure (Figure 1E),
the DNA degradation analysis showed the same results (Figure
S1A). Calpain-1 and Calpain-2 showed no significantly variation
by Western blot (Figure S1B). In addition, flow cytometric analysis
using Annexin V/PI staining further confirmed that cells exposed
to 6-shogaol (20 mM) for 12 h resulted in a moderate increase in
apoptosis, after 24 h of the drug adminstration it became obvious
(Figure 1F, 1G and Figure S1C). In contrast, 6-shogaol (20, 40,
80 mM) had no or little cytotoxicity in normal human liver HL-
7702 cells (Figure 1H).
Cellular Proteins Alteration in Response to 6-shogaol
Administration by 2-DE
To further investigate the mechanism of 6-shogaol-induced
apoptosis, protein profiles of control and 6-shogaol-treated cells
were determined by 2-DE. 2-DE is one of the core technologies in
proteomics used for separation and abundance analysis of proteins
which are associated with cellular mechanisms. The alterations of
cellular protein expression with drug treatment can provide
valuable information to explore the molecular mechanism of drug
actions [27]. Figure 2A shows the representative 2-DE gel images
for total proteins extracted from SMMC-7721 cells treated without
or with 20 mM 6-shogaol for 24 h. More than 900 protein spots
were detected on the gel ranging from MW 10-200 kDa and pI 3–
10. The significantly differentially expressed protein spots (up- or
down-regulation over 1.5 fold) were selected for protein identifi-
cation. Detailed protein alterations in expression were found as
indicated by spots marked with arrows in Figure 2B. The
differentially expressed proteins with their spot number, protein
name, accession number, MW/pI values and scores are listed in
Table 1. These altered proteins can be classified into three
categories according to their main functions and locations in cells.
The first group is located in the ER, which is related to protein
synthesis and folding, including GRP78/Bip, GRP94, HSP90,
Calreticulin, HSP70 and PDIA6, etc (Figure 2D). The second
group is involved in energy production and mitochondrial
translation, including ATP synthase subunit beta (ATP5B),
VDAC2 and mitochondria chaperonins HSP60, etc (Figure 2C).
Other altered proteins including up-regulated of keratin 7, keratin
8, keratin 18 and down-regulated of T-complex protein 1 (Tcp20)
subunit zeta are located in cytoskeleton. In addition, calcium ion
binding protein Annexin A5 and translation protein Apolipopro-
tein A-I were up-regulated (Figure 2C). Expression of GRP78,
GRP94, HSP70 and HSP60 were verified by western blot
(Figure 2E). The proteomic analysis by 2-DE revealed that ER
stress-related proteins were significantly up-regulated in response
to 6-shogaol treatment, suggesting that ER stress was involved in
6-shogaol induced apoptosis.
6-shogaol Stimulated UPR and Induced Apoptosis
through PERK/eIF2a Passway in SMMC-7721 Cells
UPR is an important genomic response to ER stress. Time-
dependent effects of 6-shogaol were examined in relation to UPR.
As shown in Figure 3A, exposure of cells to 6-shogaol resulted in
marked increase in expression of UPR targets Grp78/Bip, Grp94
and HSP70 in a time-dependent manner. Exposure of cells to 6-
shogaol also resulted in PARP degradation and caspase-3
activation (Figure 3A and 3B). Interestingly, the levels of
phospho-PERK, eIF2a and phospho-eIF2a were significantly
increased at early time points (1, 3 and 6 h) (Figure 3C) but
obvious apoptosis did not occur (Figure 1G). However, phospho-
PERK and phospho-eIF2a were slightly decreased after 12 h,
accompanied by increased apoptosis (Figure 1G and 3C). In
contrast, 6-shogaol had little or no effect on the expression of other
two UPR components IRE1 and ATF6 (Figure 3C). The present
results suggest that PERK/eIF2a passway plays a vital role in 6-
shogaol-induced apoptosis in SMMC-7721 cells, and apoptosis is
augmented with the inhibition of the phosphorylation of eIF2a.I t
is reported that ER stress activates transcription factor C/EBP
homologous protein (CHOP) and induces apoptosis through
promoting ER client protein biosynthesis by dephosphorylating
eIF2a [28]. In our investigation, the up-regulation of CHOP was
observed in a time-dependent manner (Figure 3C).
Salubrinal Synergizes with 6-shogaol to Induce Apoptosis
in SMMC-7721 Cells
Recently, several reports have demonstrated that eIF2a
phosphorylation is required for cell survival. The absence of
eIF2a phosphorylation enhances cell death [29,30]. Salubrinal
selectively blocks dephosphorylation of eIF2a and protects cells
against ER stress-mediated apoptosis [20]. We therefore examined
whether salubrinal protects SMMC-7721 cells against 6-shogaol-
induced apoptosis. Unexpectedly, salubrinal potentiated the pro-
apoptotic effect of 6-shogaol. As shown in Figure 4A, co-treatment
with salubrinal and 6-shogaol for 3 and 6 h resulted in slight
increase in apoptosis. Similarly, co-administration for 12 and 24 h
resulted in significant increase in apoptosis (20.4464.96% and
46.5863.85%) compared to 6-shogaol treated alone
(14.8660.53% and 29.1260.95%) (p,0.01, n=3). Cytotoxicity
of 6-shogaol enhanced by salubrinal was also reflected by
degradation of PARP and activation of caspase-3 (Figure 4B).
Taken together, these results suggest that salubrinal synergizes
with 6-shogaol to induce apoptosis in SMMC-7721 cells.
6-Shogaol Induces Apoptosis in SMMC-7721 Cells
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Phosphorylation and Up-Regulate CHOP Expression in
SMMC-7721 Cells
We then investigated the role of salubrinal on eIF2a in
SMMC-7721 cells. We performed a time course analysis of
eIF2a phosphorylation in SMMC-7721 cells exposed to salu-
brinal and/or 6-shogaol. As shown in Figure 4C, Salubrinal
increased the level of total eIF2a at 3 h, and reached near-
maximal level at 12 h, then decreased to basic level at 24 h.
Salubrinal alone increased eIF2a phosphorylation at different
time points. And salubrinal treatment alone had no cytotoxic
effect on SMMC-7721 cells. However, co-administration of
salubrinal and 6-shogaol for different time intervals (3, 6, 12, and
24 h) resulted in marked inhibition of eIF2a phosphorylation.
Meanwhile, a strong induction of the pro-apoptotic gene CHOP
was observed. These results suggest that salubrinal significantly
promoted apoptosis mediated by 6-shogaol through inhibition of
eIF2a phosphorylation and induction of pro-apoptotic mediator
CHOP in SMMC-7721 cells.
Enforced Activation of eIF2a Potentiates eIF2a
Phosphorylation and Attenuates 6-Shogaol-mediated
Apoptosis
To further elucidate the functional role of eIF2a in 6-shogaol-
mediated lethality, SMMC-7721 cells over-expressing eIF2a
were employed. As shown in Figure 5A, eIF2a over-expressing
cells were markedly less sensitive to 6-shogaol-induced apoptosis
than pWPI vector cells (p,0.01). Consistent with these findings,
6-shogaol was considerably less effective in triggering activation
of caspase-3 and PARP degradation in eIF2a over-expressing
cells compared to pWPI vector cells (Figure 5B and 5C). The
levels of total eIF2a and phospho-eIF2a clearly increased in
eIF2a over-expressing cells. There was hardly any inhibition of
6-shogaol induced eIF2a phosphorylation in these cells
Figure 2. 2-DE images of total cellular proteins extracted from 6-shogaol-treated SMMC-7721 cells. (A) SMMC-7721 cells were treated
with or without 20 mM 6-shogaol for 24 h. Differentially expressed spots are shown by the arrows. (B) The expanded region of altered protein spots,
the proteins with arrow are the differentially expressed proteins identified by MS. (C) The intensity of mitochondria-related and other proteins. (D)
The intensity of ER-related proteins. (E) Western bolt imaging of GRP94, GRP78, HSP70 and HSP60. For Western blot analysis, each lane was loaded
with 30 mg of protein. Blots were subsequently stripped and reprobed with antibody against b-actin to ensure equivalent loading and transfer. Two
additional studies yielded equivalent results.
doi:10.1371/journal.pone.0039664.g002
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PLoS ONE | www.plosone.org 6 June 2012 | Volume 7 | Issue 6 | e39664(Figure 5D). Together, these findings indicate that eIF2a may
play a protective role against 6-shogaol-mediated lethality.
Inhibition of eIF2a by siRNA Reduces eIF2a
Phosphorylation and Enhances 6-shogaol-Mediated
Apoptosis
In order to investigate the role eIF2a played in 6-shogaol-
mediated apoptosis, a genetic approach utilizing eIF2a siRNA
(siRNA-1 and siRNA-2) was also employed. Transfection of
SMMC-7721 cells with eIF2a siRNA reduced expression of eIF2a
apparently. Accordingly, phosphorylation of eIF2a in cells
transfected with eIF2a siRNA was substantially reduced
(Figure 5H). As shown in Figure 5E, SMMC-7721 cells transfected
with eIF2a siRNA were significantly more sensitive to 6-shogaol-
mediated lethality than pLKO.1-SH control vector treated cells
(p,0.01). Consistent with these results, 6-shogaol was considerably
more effective in triggering activation of caspase-3 and PARP
degradation in eIF2a siRNA cells (Figures 5F and 5G). Taken
together, these findings indicate that inhibition of eIF2a
phosphorylation enhances apoptosis in 6-shogaol treated
SMMC-7721 cells.
6-Shogaol Exhibits Antitumor Activity in SMMC-7721
Xenografts
To verify the therapeutic effect of 6-shogaol, we further
applied 6-shogaol to SMMC-7721 xenografts to evaluate its
significance in vivo. As shown in Figure 6A, treatment with 6-
shogaol significantly inhibited tumor growth. The mean volume
of tumors in mice treated with 6-shogaol (10 mg/kg and
50 mg/kg) was much smaller than the tumors in the vehicle-
control mice (p,0.01). There is no significant difference in body
weight between 6-shogaol treatment and vehicle-control group
(Figure 6B), indicating that no severe toxicity was observed.
To evaluate whether administration of 6-shogaol induces
apoptosis in SMMC-7721 cells in vivo, tumor sections from vehicle
and 6-shogaol-treated mice were stained with H&E or TUNEL.
As shown in Figure 6C (top panel), the sections of SMMC-7721
xenografts from mice treated with 6-shogaol showed that cancer
cells markedly decreased, with signs of necrosis with infiltration of
inflammatory cells, fibrosis, as well as apoptotic regions, identified
by their amorphous shape and condensed nuclei. Feature of
apoptosis were also observed in the tumor sections stained with
TUNEL. The sections of tumor from 6-shogaol-treated mice
showed numerous dark brown colored apoptotic cells (Figure 6C,
middle panel).
To further correlate the anti-tumor molecular mechanism of 6-
shogaol in vitro, tumor sections from vehicle and 6-shogaol-treated
mice were investigated by immunohistochemistry analysis to
detect clevead-caspase-3, phospho-PERK, eIF2a and phospho-
eIF2a. As expected, phospho-PERK, eIF2a and phospho-eIF2a
(Figure 6D) decreased, and cleveage-caspase-3 increased in 6-
shogaol-treated tumor (Figure 6C bottom panel).
Overall, these findings demonstrate that 6-shogaol administra-
tion significantly inhibites SMMC-7721 xenograft growth without
causing any side effects to the mice. 6-shogaol-mediated antitumor
activity in vivo is associated with induction of apoptosis and
inhibition of eIF2a phosphorylation.
Figure 3. Effects of 6-shogaol on ER stress signaling proteins. The cells were treated with or without 20 mM 6-shogaol for 1, 3, 6, 12, and 24 h.
Total cellular extracts were prepared and subjected to Western blot analysis using antibodies against PARP, caspase-3 and ER stress-related molecular
chaperones (A) and ER stress related proteins (C). CF stands for cleavage fragments of PARP. The caspase-3 activity (B) was assayed according to
Caspase-3 Activity Assay Kit. *Values for cells treated with 6-shogaol were significantly greater than the control group by Student’s t-test (P,0.05);
**(P,0.01).
doi:10.1371/journal.pone.0039664.g003
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In the present study, we demonstrated that 6-shogaol induced
apoptosis in SMMC-7721 cells and showed very low cytotoxicity
in normal liver HL-7702 cells. The possible cellular mechanism of
6-shogaol-induced apoptosis was investigated. 6-Shogaol could
stimulate ER stress in SMMC-7721 cells. Exposed to 6-shogaol for
a long time could induce prolonged ER stress. Dephosphorylation
of PERK/eIF2a and activate the downstream CHOP expression
triggered caspase cascade reaction to induce apoptosis in SMMC-
7721 cells.
The proteomic analysis revealed that ER molecular chaperones
were significantly up-regulated in response to 6-shogaol treatment,
suggesting that ER stress was induced by 6-shogaol. UPR is an
important genomic response to ER stress and is characterized by
the activation of three distinct signal transduction pathways
mediated by PERK, IRE1 and ATF6. Our findings here
demonstrated that 6-shogaol triggered UPR and selectively
activated PERK/eIF2a pathway at the early stage. At this stage,
apoptosis was not obvious. However, long time 6-shogaol
treatment induced inhibition of eIF2a phosphorylation associated
with increased apoptosis. It is suggested that eIF2a phosphoryla-
tion is a key step in maintaining a balance between survive and
death of 6-shogaol-treated SMMC-7721 cells. eIF2a phosphory-
lation shifts from a cyto-protective to a pro-apoptotic state in
response to sustained 6-shogaol treatment.
Salubrinal was reported to increase eIF2a phosphorylation and
protect cells against ER stress-mediated apoptosis [20,31,32]. In
our investigation, salubrinal treatment alone selectively blocked
dephosphorylation of eIF2a and did not affect SMMC-7721 cells
apoptosis. However, salubrinal specifically potentiated 6-shogaol-
induced apoptosis in SMMC-7721 cells by inhibition of eIF2a
phosphorylation and induction of the pro-apoptotic gene CHOP.
It can be concluded that in SMMC-7721 cells, increased eIF2a
phosphorylation by salubrinal encouraged the ER stress induced
by 6-shogaol, so the excessive ER stress could be achieved in
advance. Apoptosis was triggered at an early stage. The cellular
mechanism of synergetic apoptotic effect of salubrinal and 6-
shogaol needs to be further investigated. However, it was
confirmed that inhibition of eIF2a phosphorylation and increased
expression of CHOP enhanced the lethality of 6-shogaol in
SMMC-7721 cells. Clearly, over-expression of eIF2a, and
induction of eIF2a phosphorylation, largely reversed the lethal
consequences of 6-shogaol exposure, including caspase activation,
PARP cleavage, and apoptosis. On the other hand, genetic
interruption of eIF2a with siRNA, which substantially diminished
eIF2a phosphorylation, potentiated 6-shogaol-mediated lethality.
It is demonstrated that eIF2a phosphorylation is required for cell
survival, the absence of eIF2a phosphorylation enhances cell
death.
Recent studies have shown that 6-shogaol is a strong inducer of
apoptosis in diverse cancer cells [4-8]. However, it is unclear
Figure 4. Effects of co-administration of salubrinal and 6-shogaol on apoptosis and phosphorylation of eIF2a. SMMC-7721 cells were
pretreated with 5 mM salubrinal for 2 h, followed by treatment with 20 mM 6-shogaol for 3, 6, 12, and 24 h. (A) Apoptosis was determined using flow
cytometry. *Values for cells treated with salubrinal and 6-shogaol in combination were significantly greater than those for cells treated with 6-shogaol
alone by Student’s t-test; P,0.05. Total protein extracts were prepared and subjected to Western blot assay using antibodies against PARP and
caspase-3 (B), and eIF2a pathway related proteins (C). CF stands for cleavage fragments of PARP.
doi:10.1371/journal.pone.0039664.g004
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response to treatment with this compound in vitro. In the present
study, we have shown that induction of apoptosis by 6-shogaol
indeed occurred in vivo, which could be responsible for the
inhibitory effects on tumor growth by 6-shogaol. Consistent with
the in vitro data, our in vivo results indicate that suppression of
phospho-PERK, phospho-eIF2a, and eIF2a is closely correlated
with the reduction of SMMC-7721 tumor xenografts, further
supporting our notion.
Figure 5. The role of eIF2a in 6-shogaol-induced apoptosis. SMMC-7721 cells were stably transfected with an empty vector (pWPI) or over-
expression form of eIF2a as described in Materials and methods. All cells were then treated with 20 mM 6-shogaol for 24 h. (A) After treatment,
apoptosis was determined using flow cytometry. **P,0.01. Total cellular extracts were prepared and subjected to (C) caspase-3 activity assay and
Western blot assay using antibodies against PARP, caspase-3 (B) and PERK/eIF2a signaling proteins (D). SMMC-7721 cells were also stably transfected
with an empty vector pLKO.1-SH or eIF2a siRNA (two clones siRNA-1 and siRNA-2). Cells were then treated with 20 mM 6-shogaol for 24 h. (E) After
treatment, apoptosis was determined using flow cytometry. **P,0.01. Total cellular extracts were prepared and subjected to (G) caspase-3 activity
assay and Western blot analysis using antibodies against PARP, caspase-3 (F) and PERK/eIF2a signaling proteins (H). CF stands for cleavage fragments
of PARP.
doi:10.1371/journal.pone.0039664.g005
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PLoS ONE | www.plosone.org 9 June 2012 | Volume 7 | Issue 6 | e39664In conclusion, the present findings indicate that 6-shogaol
induces apoptosis, caspase activation, and PARP cleavage in both
SMMC-7721 cells and SMMC-7721 tumor xenografts through an
ER stress-associated mechanism. Our data indicate that attenu-
ation of eIF2a phosphorylation and up-regulation of CHOP may
contribute to 6-shogaol-mediated apoptosis in SMMC-7721 cells.
Because 6-shogaol selectively kills HCC cells without a significant
toxic effect on normal liver cells and had little toxicity in SMMC-
7721 xenograft mice, it seems that 6-shogaol may have clinical
implications for therapeutic intervention against HCC or other
malignancies. Our findings also show that salubrinal enhances 6-
shogaol induced apoptosis through inhibition of eIF2a phosphor-
ylation. The combination of 6-shogaol and salubrinal treatment
may be considered as a novel therapeutic strategy in HCC.
Supporting Information
Figure S1 Effect of 6-shogaol on apoptosis in SMMC-
7721 cells. (A) Cells (1610
6) were treated with 20 mM 6-shogaol
for 6, 12, 24 h and stained with PI for flow cytometry assay (BD
FACS Calibur) 20,000 cells were analyzed using the DNA analysis
software (ModFitLT V3.2). (B) SMMC-7721 cells were treated
without or with 20 mM 6-shogaol for 3, 6, 12, 24 h. Total cellular
extracts were prepared and subjected to Western blot analysis
using antibodies against calpain-1 and calpain-2. (C) SMMC-7721
cells were treated with 20 mM 6-shogaol for 3, 6, 12, 24 and 48 h.
The cells were stained with Annexin V/PI, and apoptosis was
determined using flow cytometry [25]. (D) Cells (1610
6) were
Figure 6. In vivo antitumor effects of 6-shogaol in SMMC-7721 xenografts. SCID mice were inoculated with SMMC-7721 cells (3610
6 cells/
mouse, s.c.) and randomly divided into three groups (8/group) treated with 6-shogaol (10 mg/kg and 50 mg/kg, i.p., daily) or vehicle control solvent.
(A) Average tumor volume in vehicle control mice and mice treated with 10 mg/kg and 50 mg/kg 6-shogaol. ** P,0.01. (B) Body weight changes of
mice during the 28 days of study. (C) Representative photographs of biopsy samples from mice treated with 6-shogaol (50 mg/kg) and vehicle
control. Original magnification 6400. (D) Expression of p-PERK, eIF2a, and p-eIF2a in tumor tissues of SMMC-7721 xenograft mouse model treated
with 6-shogaol (50 mg/kg) and vehicle control.
doi:10.1371/journal.pone.0039664.g006
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Hoechst 33258. Original magnification 6400.
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